ATE542794T1 - Pyrrolderivat oder salz davon - Google Patents
Pyrrolderivat oder salz davonInfo
- Publication number
- ATE542794T1 ATE542794T1 AT07714469T AT07714469T ATE542794T1 AT E542794 T1 ATE542794 T1 AT E542794T1 AT 07714469 T AT07714469 T AT 07714469T AT 07714469 T AT07714469 T AT 07714469T AT E542794 T1 ATE542794 T1 AT E542794T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor
- treatment
- compound
- pyrrole derivative
- ibs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006041830 | 2006-02-20 | ||
| PCT/JP2007/052943 WO2007097276A1 (ja) | 2006-02-20 | 2007-02-19 | ピロール誘導体またはその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE542794T1 true ATE542794T1 (de) | 2012-02-15 |
Family
ID=38437316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07714469T ATE542794T1 (de) | 2006-02-20 | 2007-02-19 | Pyrrolderivat oder salz davon |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8222274B2 (de) |
| EP (1) | EP1988075B1 (de) |
| JP (1) | JP5157893B2 (de) |
| KR (1) | KR20080105092A (de) |
| CN (1) | CN101384549B (de) |
| AT (1) | ATE542794T1 (de) |
| CA (1) | CA2642619A1 (de) |
| ES (1) | ES2379734T3 (de) |
| MX (1) | MX2008010644A (de) |
| WO (1) | WO2007097276A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200638926A (en) * | 2005-02-08 | 2006-11-16 | Astellas Pharma Inc | A therapeutic agent for irritable bowel disease |
| CN101243046A (zh) * | 2005-08-08 | 2008-08-13 | 安斯泰来制药有限公司 | 酰基胍衍生物或其盐 |
| CA2696429A1 (en) * | 2007-08-22 | 2009-02-26 | Allergan, Inc. | Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity |
| CA2741511C (en) * | 2008-11-21 | 2017-01-24 | Raqualia Pharma Inc. | Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity |
| EP2670744B1 (de) * | 2011-02-03 | 2015-05-27 | Lupin Limited | Pyrrolderivate als modulatoren von alpha7-nachr |
| WO2013079223A1 (en) | 2011-12-02 | 2013-06-06 | Phenex Pharmaceuticals Ag | Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| WO2018058109A1 (en) | 2016-09-26 | 2018-03-29 | Nusirt Sciences, Inc. | Compositions and methods for treating metabolic disorders |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3410857A (en) * | 1964-10-12 | 1968-11-12 | Endo Lab | 2-amino ethyl pyrrol-3-yl ketones |
| US3391157A (en) * | 1965-04-23 | 1968-07-02 | Endo Lab | 2, 4, 5-triloweralkyl-pyrrol-3-yl-hydroxymethyl ketones and ethers and carbamates thereof |
| US3407199A (en) * | 1966-01-18 | 1968-10-22 | Endo Lab | Tertiaryamino ethyl or propyl pyrrol-2-yl ketones |
| US3551571A (en) * | 1967-05-19 | 1970-12-29 | Endo Lab | Methods for reducing pain,reducing fever and alleviating inflammatory syndromes with heteroaromatic pyrrol-3-yl ketones |
| AU664392B2 (en) * | 1991-10-18 | 1995-11-16 | Monsanto Technology Llc | Fungicides for the control of take-all disease of plants |
| CA2121391A1 (en) | 1993-04-28 | 1994-10-29 | Atsuyuki Kojima | Indoloylguanidine derivatives |
| EP0639573A1 (de) | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament |
| EP0749313A4 (de) * | 1994-03-11 | 2001-10-24 | Lilly Co Eli | Verfahren zur behandlung von mit dem 5-ht2b-rezeptor verbundenen zuständen |
| US5663178A (en) | 1995-02-06 | 1997-09-02 | Eli Lilly And Company | Tetrahydro-beta carbolines |
| JP3295277B2 (ja) | 1994-06-01 | 2002-06-24 | 呉羽化学工業株式会社 | 抗腎疾患剤及びベンズイミダゾール誘導体 |
| TW440563B (en) | 1996-05-23 | 2001-06-16 | Hoffmann La Roche | Aryl pyrimidine derivatives and a pharmaceutical composition thereof |
| GB9612884D0 (en) | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| JP4196419B2 (ja) | 1997-11-05 | 2008-12-17 | ソニー株式会社 | データ送受信システム、データ受信装置及びデータ送受信方法 |
| WO2000069437A1 (en) | 1999-05-18 | 2000-11-23 | Synaptic Pharmaceutical Corporation | Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder |
| AU6762400A (en) | 1999-08-12 | 2001-03-13 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
| US6444477B1 (en) * | 2000-11-28 | 2002-09-03 | Pharmagene Laboratories Limited | Assay method for detecting 5-HT2B antagonists |
| ITRM20010356A1 (it) * | 2001-06-21 | 2002-12-23 | Sigma Tau Ind Farmaceuti | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. |
| BR0214035A (pt) | 2001-11-08 | 2005-04-26 | Elan Pharm Inc | Composto |
| CA2471754A1 (en) | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Androgen receptor antagonist |
| JP4316232B2 (ja) * | 2001-12-28 | 2009-08-19 | 武田薬品工業株式会社 | アンドロゲン受容体拮抗剤 |
| FR2842524B1 (fr) * | 2002-07-16 | 2005-04-22 | Aventis Pharma Sa | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments |
| JP4399862B2 (ja) * | 2002-08-09 | 2010-01-20 | 味の素株式会社 | 腸疾患および内臓痛の治療薬 |
| GB0230088D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| JP4444120B2 (ja) * | 2003-01-02 | 2010-03-31 | エフ．ホフマン−ラ ロシュ アーゲー | 新規なｃｂ１受容体逆アゴニスト |
| JP2005162657A (ja) | 2003-12-02 | 2005-06-23 | Takeda Chem Ind Ltd | カンナビノイド受容体調節剤 |
| WO2005079845A1 (ja) | 2004-02-20 | 2005-09-01 | Astellas Pharma Inc. | 片頭痛予防薬 |
| RU2006107371A (ru) | 2004-02-20 | 2006-09-10 | Астеллас Фарма Инк. (Jp) | Флуореновые производные |
| ES2324720T3 (es) | 2004-05-10 | 2009-08-13 | F. Hoffmann-La Roche Ag | Pirrol o imidazol amidas para tratar la obesidad. |
| TW200638926A (en) * | 2005-02-08 | 2006-11-16 | Astellas Pharma Inc | A therapeutic agent for irritable bowel disease |
| CN101243046A (zh) | 2005-08-08 | 2008-08-13 | 安斯泰来制药有限公司 | 酰基胍衍生物或其盐 |
| CN102659774A (zh) * | 2005-08-15 | 2012-09-12 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3拮抗剂的哌啶和哌嗪衍生物 |
| WO2007094513A2 (en) * | 2006-02-16 | 2007-08-23 | Takeda Pharmaceutical Company Limited | Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| RU2008137612A (ru) | 2006-02-20 | 2010-03-27 | Астеллас Фарма Инк. (Jp) | Амидное производное или его соли |
-
2007
- 2007-02-19 WO PCT/JP2007/052943 patent/WO2007097276A1/ja active Application Filing
- 2007-02-19 CA CA002642619A patent/CA2642619A1/en not_active Abandoned
- 2007-02-19 ES ES07714469T patent/ES2379734T3/es active Active
- 2007-02-19 US US12/278,609 patent/US8222274B2/en not_active Expired - Fee Related
- 2007-02-19 CN CN2007800059535A patent/CN101384549B/zh not_active Expired - Fee Related
- 2007-02-19 EP EP07714469A patent/EP1988075B1/de not_active Not-in-force
- 2007-02-19 AT AT07714469T patent/ATE542794T1/de active
- 2007-02-19 JP JP2008501700A patent/JP5157893B2/ja not_active Expired - Fee Related
- 2007-02-19 MX MX2008010644A patent/MX2008010644A/es not_active Application Discontinuation
- 2007-02-19 KR KR1020087022898A patent/KR20080105092A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1988075B1 (de) | 2012-01-25 |
| CN101384549A (zh) | 2009-03-11 |
| US8222274B2 (en) | 2012-07-17 |
| CA2642619A1 (en) | 2007-08-30 |
| CN101384549B (zh) | 2011-04-13 |
| WO2007097276A1 (ja) | 2007-08-30 |
| EP1988075A4 (de) | 2010-03-03 |
| JP5157893B2 (ja) | 2013-03-06 |
| ES2379734T3 (es) | 2012-05-03 |
| JPWO2007097276A1 (ja) | 2009-07-16 |
| KR20080105092A (ko) | 2008-12-03 |
| EP1988075A1 (de) | 2008-11-05 |
| US20090036421A1 (en) | 2009-02-05 |
| MX2008010644A (es) | 2008-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE542794T1 (de) | Pyrrolderivat oder salz davon | |
| WO2006100635A3 (en) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
| ATE446962T1 (de) | Thiazolopyridinon-derivate als mch- rezeptorantagonisten | |
| MY154909A (en) | Novel thiophene derivatives | |
| ZA200807274B (en) | Novel pyridine derivatives | |
| TW200700406A (en) | Novel thiophene derivatives | |
| TW200716591A (en) | Novel thiophene derivatives | |
| TW200708511A (en) | Novel thiophene derivatives | |
| WO2009016564A3 (en) | 2-aza-bicyclo[3.3.0]octane derivatives | |
| TW200738670A (en) | Novel thiophene derivatives | |
| IL201317A0 (en) | Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists | |
| PL1807434T3 (pl) | Tienopirydyny jako allosteryczne środki wzmacniające receptor M4 muskarynowy | |
| WO2008060621A3 (en) | Aminopyrrolidines as chemokine receptor antagonists | |
| WO2006066173A3 (en) | Novel mch receptor antagonists | |
| WO2007103187A3 (en) | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists | |
| NO20084009L (no) | Amidderivat eller salt derav | |
| WO2007150026A3 (en) | Purinone derivatives as hm74a agonists | |
| MX2009005358A (es) | Derivados de 5-sulfanilmetil-pirazolo[1,5-a]pirimidin-7-ol como antagonistas de cxcr2. | |
| WO2007056091A3 (en) | 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof | |
| WO2009023539A3 (en) | Tetrahydropyridine carboxamide derivatives as trpvl antagonists | |
| ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
| ATE418548T1 (de) | Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten | |
| WO2010018549A3 (en) | Therapeutic compositions containing macitentan | |
| MX2010002171A (es) | Compuestos 8-azabiciclo[3.2.1] octil-2 hidroxibenzamida como antagonistas de los receptores opioides mu. | |
| WO2009089062A3 (en) | Cadherin-11 ecl domain antagonists for treating inflammatory joint disorders |